Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data

30 Sept 2016

Abstract excerpt

BACKGROUND: Worldwide, respiratory syncytial virus (RSV) is considered to be the most important viral cause of respiratory morbidity and mortality among infants and young children. Although no active vaccine is available on the market yet, there are several active vaccine development programs in various stages. To assess whether one of these vaccines might be a future asset for national immunization programs,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Impact on Reproduction
Share to Delphi Technique in Research
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27689356
DOI: 10.1371/journal.pone.0163567

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa DataPMID 27689356Read ↗

Cost-effectiveness of the next generation of RSV intervention strategiesSemantic proximity Read ↗

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaSemantic proximity Read ↗

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016Semantic proximity Read ↗

Cost-effectiveness of respiratory syncytial virus vaccination for older adults: a modelling analysisSemantic proximity Read ↗

Clinical and economic burden of Respiratory Syncytial Virus in children aged 0-5 years in ItalySemantic proximity Read ↗

Modelling the transmission dynamics of RSV and the impact of routine vaccinationSemantic proximity Read ↗

Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysisSemantic proximity Read ↗

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsSemantic proximity Read ↗

Economic Burden and Return on Investment of Immunization Programs in Saudi Arabia: A Health Economic EvaluationSemantic proximity Read ↗

Pregnant women's choices for preventing respiratory syncytial virus (RSV)Semantic proximity Read ↗

Evaluation of the costs of care for pediatric patients hospitalized for RSV: a retrospective cohort study in BelgiumSemantic proximity Read ↗

Estimation of GP visits, hospitalizations and deaths attributable to RSV and influenza and costs associated with hospitalizations in older adults in France, 2010-2020Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.